Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mohamed Roshdy El-Masry"'
Autor:
Noha M. El Husseiny, Alshymaa Ahmed Salama, Asmaa M. Abdelhameed, Amal El-Beshlawy, Mohamed Roshdy El-Masry
Publikováno v:
Scientific Reports
The development of hemolytic erythrocyte alloantibodies and autoantibodies complicates transfusion therapy in thalassemia patients. These antibodies ultimately increase the need for blood and intensify transfusion complications. There is a scanty dat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::907f8cccf59b62c993f5a8aace1c3fca
https://doi.org/10.1038/s41598-020-78333-y
https://doi.org/10.1038/s41598-020-78333-y
Autor:
Sahar Nassef, Marwa Salah, Mervat M. Mattar, Noha M. El Husseiny, Mohamed Abdelkader Morad, Ahmed Abdul Gawad, Mohamed Roshdy El Masry
Publikováno v:
Clinical lymphoma, myelomaleukemia. 19(8)
Background Identification of janus kinase 2 (JAK2) mutation even in absence of myeloproliferative disorders (MPNs) was found to be related to venous thromboembolism occurrence. Venous thrombosis screening is not routinely requested in patients with m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3b8e16a5a305f19812448ebbbeb56ae
https://pubmed.ncbi.nlm.nih.gov/32067955
https://pubmed.ncbi.nlm.nih.gov/32067955
Autor:
Mervat M. Mattar, Mohamed Abd El Kader Murad, Mohamed Roshdy El Masry, Marwa Salah, Sahar Nassef, Ahmed Abd Gawad, Noha M. El Husseiny
Publikováno v:
SSRN Electronic Journal.
Background: Identification of JAK-2 mutation even in absence of myeloproliferative disorders was found to be related to venous thromboembolism occurrence. The aim of this work is to screen MPN patients for venous thrombosis and study its correlation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fbefe7dfc74097ecd99fe20c222dae2
https://doi.org/10.2139/ssrn.3225491
https://doi.org/10.2139/ssrn.3225491
Publikováno v:
Meta Gene
Aim CHP2 (calcineurin B homologous protein 2) is identified as a tumor-associated antigen highly expressed in different malignancies. It plays a critical role in cancer cell development, proliferation, motility and survival. It is suggested that the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c6dafbe64e722719b0c2ff5ed28811e
http://europepmc.org/articles/PMC4287875
http://europepmc.org/articles/PMC4287875
Autor:
Mohamed Abdelkader Morad, Noha M. El Husseiny, Mervat M. Mattar, Ahmed Abdul Gawad, Mohamed Roshdy El Masry, Marwa Salah, Sahar Nassef
Publikováno v:
Blood. 132:5476-5476
Background : Identification of JAK-2 mutation even in absence of myeloproliferative disorders was found to be related to venous thromboembolism occurrence. The aim of this work is to screen myeloproliferative neoplasm ( MPN) patients for venous throm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1b552b4ced382b1a90f1deadf5c7d95
https://doi.org/10.1182/blood-2018-99-116025
https://doi.org/10.1182/blood-2018-99-116025